F. Gobeil

发表

Receptors for kinins in the human isolated umbilical vein

A. Pizard, A. Rizzi, D. Regoli, 1996, British journal of pharmacology.

Human urotensin-II enhances plasma extravasation in specific vascular districts in Wistar rats.

D. Regoli, F. Gobeil, P. Sirois, 2004, Canadian journal of physiology and pharmacology.

The Human Gonadotropin Releasing Hormone Type I Receptor Is a Functional Intracellular GPCR Expressed on the Nuclear Membrane

C. McArdle, P. Conn, A. Babwah, 2010, PloS one.

Duration of Catheter Use in Patients with Diabetes Using Continuous Subcutaneous Insulin Infusion: A Review.

R. Rabasa-Lhoret, V. Messier, N. Taleb, 2018, Diabetes technology & therapeutics.

Altered Vascular Function in Fetal Programming of Hypertension

A. Nuyt, X. Hou, I. Lahaie, 2002, Stroke.

Efficacy of Combining PRP and MMP Inhibitors in Treating Moderately Damaged Tendons Ex Vivo

H. Hassanisaber, F. Gobeil, M. Savard, 2019, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

Correction: Induction of Selective Blood-Tumor Barrier Permeability and Macromolecular Transport by a Biostable Kinin B1 Receptor Agonist in a Glioma Rat Model

M. Lepage, W. Müller-Esterl, L. Tremblay, 2012, PLoS ONE.

Induction of Selective Blood-Tumor Barrier Permeability and Macromolecular Transport by a Biostable Kinin B1 Receptor Agonist in a Glioma Rat Model

M. Lepage, W. Müller-Esterl, L. Tremblay, 2012, PloS one.

Pro-inflammatory disequilibrium of the IL-1 beta/IL-1ra ratio in an experimental model of perinatal brain damages induced by lipopolysaccharide and hypoxia-ischemia.

S. Girard, G. Sébire, F. Gobeil, 2008, Cytokine.

Characterization of moderate tendinopathy in ex vivo stress-deprived rat tail tendons

F. Gobeil, M. Savard, È. Langelier, 2019, BioMedical Engineering OnLine.

Contractile Responses of Aortae from WKY and SHR to Vasoconstrictors

D. Regoli, F. Gobeil, P. D'Orléans-Juste, 2004, Clinical and experimental hypertension.

Pharmacological Modulation of Blood–Brain Barrier Permeability by Kinin Analogs in Normal and Pathologic Conditions

M. Lepage, S. Chemtob, R. Lebel, 2020, Pharmaceuticals.

Kallikrein-kinin system as the dominant mechanism to counteract hyperactive renin-angiotensin system.

D. Regoli, F. Gobeil, 2017, Canadian journal of physiology and pharmacology.

Selective tumor blood–brain barrier opening with the kinin B2 receptor agonist [Phe8 ψ(CH2NH)Arg9]-BK in a F98 glioma rat model: An MRI study

M. Lepage, L. Tremblay, D. Fortin, 2010, Neuropeptides.

Expression of endogenous nuclear bradykinin B2 receptors mediating signaling in immediate early gene activation

W. Müller-Esterl, F. Gobeil, M. Savard, 2008, Journal of cellular physiology.

Critical insights into the beneficial and protective actions of the kallikrein-kinin system.

D. Regoli, F. Gobeil, 2015, Vascular pharmacology.

B1 and B2 kinin receptors in various species.

G. Calo’, A. Rizzi, D. Regoli, 1997, Immunopharmacology.

Targeting intracellular B2 receptors using novel cell-penetrating antagonists to arrest growth and induce apoptosis in human triple-negative breast cancer

A. Giordano, S. Chemtob, F. Rizzolio, 2018, Oncotarget.

Structure-activity studies of B1 receptor-related peptides. Antagonists.

W. Neugebauer, D. Regoli, L. Pheng, 1996, Hypertension.

Cyclooxygenase-2 in Human and Experimental Ischemic Proliferative Retinopathy

Y. Courtois, F. Behar-Cohen, S. Chemtob, 2003, Circulation.

RNA Isolation and Reverse Transcription – Polymerase Chain Reaction ( PCR )

Y. Courtois, F. Behar-Cohen, S. Chemtob, 2003 .

Mouse Mast Cell Protease 4 Deletion Protects Heart Function and Survival After Permanent Myocardial Infarction

R. Lecomte, S. Takai, M. Lepage, 2018, Front. Pharmacol..

Preservation of neural function in the perinate by high PGE(2) levels acting via EP(2) receptors.

M. Roy, P. Hardy, S. Chemtob, 2000, Journal of applied physiology.

PGE(2)-mediated eNOS induction in prolonged hypercapnia.

P. Hardy, X. Hou, S. Chemtob, 2002, Investigative ophthalmology & visual science.

Prolonged Hypercapnia-Evoked Cerebral Hyperemia via K+ Channel– and Prostaglandin E2–Dependent Endothelial Nitric Oxide Synthase Induction

P. Hardy, X. Hou, S. Chemtob, 2000, Circulation research.

Ascorbic acid decreases the binding affinity of the AT1 receptor for angiotensin II.

Christophe D. Proulx, R. Leduc, P. Leclerc, 2008, American journal of hypertension.

Nitric Oxide Signaling via Nuclearized Endothelial Nitric-oxide Synthase Modulates Expression of the Immediate Early Genes iNOS and mPGES-1*

N. Heveker, E. Goetzl, J. Gratton, 2006, Journal of Biological Chemistry.

Angiotensin II AT1 receptor internalization, translocation and de novo synthesis modulate cytosolic and nuclear calcium in human vascular smooth muscle cells.

Sama F. Sleiman, S. Choufani, C. Asselin, 2003, Canadian journal of physiology and pharmacology.

Hypotensive effects of hemopressin and bradykinin in rabbits, rats and mice A comparative study

W. Neugebauer, D. Regoli, F. Gobeil, 2005, Peptides.

Lysophosphatidic acid induces endothelial cell death by modulating the redox environment.

P. Hardy, A. Ribeiro-da-Silva, S. Chemtob, 2007, American journal of physiology. Regulatory, integrative and comparative physiology.

Bradykinin protects against brain microvascular endothelial cell death induced by pathophysiological stimuli

Charles M. Cuerrier, M. Grandbois, F. Gobeil, 2010, Journal of cellular physiology.

Modulation of Pro-inflammatory Gene Expression by Nuclear Lysophosphatidic Acid Receptor Type-1*

E. Goetzl, X. Hou, A. Ribeiro-da-Silva, 2003, Journal of Biological Chemistry.

The Succinate Receptor SUCNR1 Resides at the Endoplasmic Reticulum and Relocates to the Plasma Membrane in Hypoxic Conditions

S. Omri, X. Hou, J. Rivera, 2022, Cells.

Selective Neuromicrovascular Endothelial Cell Death by 8-Iso-Prostaglandin F2&agr;: Possible Role in Ischemic Brain Injury

G. Almazan, X. Hou, S. Chemtob, 2003, Stroke.

Selective Kinin Receptor Agonists as Cardioprotective Agents in Myocardial Ischemia and Diabetes

M. Marre, R. Roussel, P. Bruneval, 2013, The Journal of Pharmacology and Experimental Therapeutics.

Kinins and peptide receptors

D. Regoli, F. Gobeil, 2016, Biological chemistry.

Platelet-activating factor in vasoobliteration of oxygen-induced retinopathy.

G. Almazan, X. Hou, S. Chemtob, 2002, Investigative ophthalmology & visual science.

Delayed myocardial protection induced by endotoxin does not involve kinin B1‐receptors

C. Ribuot, D. Regoli, F. Gobeil, 2000, British journal of pharmacology.

Urotensin II-induced hypotensive responses in Wistar–Kyoto (Wky) and spontaneously hypertensive (Shr) rats

D. Regoli, F. Gobeil, P. D'Orléans-Juste, 2005, Peptides.

Platelet activating factor receptors.

S. Choufani, J. Stankova, M. Rola-Pleszczynski, 2003, Advances in experimental medicine and biology.

Prostaglandin E2 increases cyclic AMP and inhibits endothelin‐1 production/secretion by guinea‐pig tracheal epithelial cells through EP4 receptors

G. Guillemette, A. Villeneuve, B. Battistini, 2001 .

Adenosine induces cyclic‐AMP formation and inhibits endothelin‐1 production/secretion in guinea‐pig tracheal epithelial cells through A2B adenosine receptors

G. Guillemette, A. Villeneuve, B. Battistini, 2000, British journal of pharmacology.

Classification of Kinin Receptors

A. Rizzi, D. Regoli, F. Gobeil, 2001, Biological chemistry.

Characterization of PGE2 receptors in fetal and newborn lamb ductus arteriosus.

G. Andelfinger, J. Fouron, S. Chemtob, 2001, American journal of physiology. Heart and circulatory physiology.

Antagonistic effects of FR 173657 on human, pig, rabbit, and guinea pig kinin receptors: an in vitro study.

G. Calo’, C. Campobasso, N. Inamura, 1997, Canadian journal of physiology and pharmacology.

Involvement of bradykinin B1 and B2 receptors in pulmonary leukocyte accumulation induced by Sephadex beads in guinea pigs.

D. Regoli, F. Gobeil, P. Sirois, 1999, European journal of pharmacology.

Bradykinin receptors and receptor ligands (with special emphasis on vascular receptors)

G. Calo’, C. Campobasso, G. Mollica, 1996, Regulatory Peptides.

In vitro and in vivo characterization of bradykinin B2 receptors in the rabbit and the guinea pig.

D. Regoli, L. Pheng, F. Gobeil, 1996, Canadian journal of physiology and pharmacology.

Bradykinin receptor types and B2 subtypes.

Q. Nguyen, J. Salvino, D. Sawutz, 1994, Life sciences.

Receptors for bradykinin and related kinins: a critical analysis.

N. Rhaleb, D. Regoli, F. Gobeil, 1993, Canadian journal of physiology and pharmacology.

Further pharmacological evaluation of a novel synthetic peptide bradykinin B2 receptor agonist

W. Neugebauer, F. Gobeil, M. Savard, 2013, Biological chemistry.

Studies on the angiotensin-converting enzyme and the kinin B2 receptor in the rabbit jugular vein: modulation of contractile response to bradykinin.

D. Regoli, F. Gobeil, P. Blais, 2002, Canadian journal of physiology and pharmacology.

In vitro and in vivo effects of kinin B1 and B2 receptor agonists and antagonists in inbred control and cardiomyopathic hamsters

J. Ouellette, C. Lambert, D. Regoli, 2000, British journal of pharmacology.

Characterization of non-peptide bradykinin B2 receptor agonist (FR 190997) and antagonist (FR 173657).

N. Inamura, D. Regoli, F. Gobeil, 1999, Immunopharmacology.

Kinin B1 receptor antagonists containing alpha-methyl-L-phenylalanine: in vitro and in vivo antagonistic activities.

W. Neugebauer, D. Regoli, F. Gobeil, 1999, Hypertension.

Effects of kinins on isolated stomachs of control and transgenic knockout B2 receptor mice

J. Hess, D. Regoli, F. Gobeil, 1998, Naunyn-Schmiedeberg's Archives of Pharmacology.

Pharmacological profiles of the human and rabbit B1 receptors.

E. Whalley, W. Neugebauer, D. Regoli, 1997, Canadian journal of physiology and pharmacology.

FR 173657: a new, potent, nonpeptide kinin B2 receptor antagonist. An in vitro study.

G. Calo’, N. Inamura, A. Rizzi, 1997, Hypertension.

Receptors for kinins: from classical pharmacology to molecular biology.

D. Regoli, L. Pheng, F. Gobeil, 1996, Immunopharmacology.

Non-selectivity of new bradykinin antagonists for B1 receptors.

N. Rhaleb, D. Regoli, F. Gobeil, 1992, Life sciences.

Cytotoxicity of the E(2)-isoprostane 15-E(2t)-IsoP on oligodendrocyte progenitors.

G. Almazan, S. Chemtob, D. Varma, 2004, Free radical biology & medicine.

Preparation and evaluation at the delta opioid receptor of a series of linear leu-enkephalin analogues obtained by systematic replacement of the amides.

L. Gendron, B. Guérin, Y. Dory, 2013, ACS chemical neuroscience.

Two NK-3 receptor subtypes: Demonstration by biological and binding assays

Q. Nguyen, D. Regoli, F. Gobeil, 1994, Neuropeptides.

High salt‐induced hypertension in B2 knockout mice is corrected by the ETA antagonist, A127722

F. Gobeil, L. Desbiens, G. Bkaily, 2013, British journal of pharmacology.

CSII: Longer Catheter Usage Time, a Reasonable Goal.

R. Rabasa-Lhoret, M. Pesant, J. Baillargeon, 2016, Journal of diabetes science and technology.

Enzymatic pathways involved in the generation of endothelin‐1(1–31) from exogenous big endothelin‐1 in the rabbit aorta

C. R. Tirapelli, F. Gobeil, P. D'Orléans-Juste, 2006, British journal of pharmacology.

Role of thromboxane in retinal microvascular degeneration in oxygen-induced retinopathy.

G. Almazan, X. Hou, S. Chemtob, 2001, Journal of applied physiology.

Prostaglandin E(2) increases cyclic AMP and inhibits endothelin-1 production/secretion by guinea-pig tracheal epithelial cells through EP(4) receptors.

G. Guillemette, A. Villeneuve, B. Battistini, 2001, British journal of pharmacology.

Regulation of eNOS Expression in Brain Endothelial Cells by Perinuclear EP3 Receptors

S. Molotchnikoff, S. Choufani, X. Hou, 2002, Circulation research.

Isomer-specific contractile effects of a series of synthetic f2-isoprostanes on retinal and cerebral microvasculature.

L. Roberts, X. Hou, S. Chemtob, 2004, Free radical biology & medicine.

Antagonists for kinin B1 and B2 receptors in the mouse

W. Neugebauer, D. Regoli, L. Pheng, 1997 .

Kinin B1 and B2 receptors in the mouse.

W. Neugebauer, D. Regoli, L. Pheng, 1995, Canadian journal of physiology and pharmacology.

Kinin Receptor Agonism Restores Hindlimb Postischemic Neovascularization Capacity in Diabetic Mice

R. Roussel, N. Bouby, L. Potier, 2015, The Journal of Pharmacology and Experimental Therapeutics.

Structure–activity relationships of novel peptide agonists of the human bradykinin B2 receptor

M. Amblard, W. Neugebauer, Jean Martinez, 2009, Peptides.

Intracellular-specific colocalization of prostaglandin E2 synthases and cyclooxygenases in the brain.

J. Mancini, X. Hou, S. Chemtob, 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

Agonist-independent Nuclear Localization of the Apelin, Angiotensin AT1, and Bradykinin B2 Receptors*

B. O'dowd, S. George, S. Chemtob, 2004, Journal of Biological Chemistry.

THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors

Stephen P. H. Alexander, Leigh A. Stoddart, Kalyan C. Tirupula, 2021, British journal of pharmacology.

Impact of kinins in the treatment of cardiovascular diseases.

G. Plante, D. Regoli, F. Gobeil, 2012, Pharmacology & therapeutics.

Bradykinin receptors and their antagonists.

A. Rizzi, D. Regoli, F. Gobeil, 1998, European journal of pharmacology.

New insights into the retinal circulation: inflammatory lipid mediators in ischemic retinopathy.

P. Hardy, S. Chemtob, F. Sennlaub, 2005, Prostaglandins, leukotrienes, and essential fatty acids.

Subcellular localization of coagulation factor II receptor-like 1 in neurons governs angiogenesis

M. Hollenberg, M. Montoya-Zavala, G. Andelfinger, 2014, Nature Medicine.

Dominant Role for Calpain in Thromboxane-Induced Neuromicrovascular Endothelial Cytotoxicity

A. Pshezhetsky, P. Hardy, I. Lahaie, 2006, Journal of Pharmacology and Experimental Therapeutics.

ISOPROSTANES ON RETINAL AND CEREBRAL MICROVASCULATURE

L. Roberts, X. Hou, S. Chemtob, 2004 .

Increased platelet-activating factor-induced periventricular brain microvascular constriction associated with immaturity.

X. Hou, S. Chemtob, F. Sennlaub, 2003, American Journal of Physiology. Regulatory Integrative and Comparative Physiology.

Proinflammatory Gene Induction by Platelet-Activating Factor Mediated Via Its Cognate Nuclear Receptor1

S. Choufani, J. Stankova, M. Rola-Pleszczynski, 2002, The Journal of Immunology.

Trans-arachidonic acids generated during nitrative stress induce a thrombospondin-1–dependent microvascular degeneration

S. Germain, G. Andelfinger, J. Falck, 2005, Nature Medicine.

Augmented vasoconstriction and thromboxane formation by 15-F(2t)-isoprostane (8-iso-prostaglandin F(2alpha)) in immature pig periventricular brain microvessels.

E. Ellis, X. Hou, S. Chemtob, 2000, Stroke.

Nuclear prostaglandin signaling system: biogenesis and actions via heptahelical receptors.

A. Ribeiro-da-Silva, S. Chemtob, P. Lachapelle, 2003, Canadian journal of physiology and pharmacology.

Redox-dependent effects of nitric oxide on microvascular integrity in oxygen-induced retinopathy.

P. Hardy, S. Chemtob, F. Sennlaub, 2004, Free radical biology & medicine.

Development of a multigram synthesis of the bradykinin receptor 2 agonist FR-190997 and analogs thereof.

T. Katsila, G. Rassias, F. Gobeil, 2023, Archiv der Pharmazie.

Targeting intracellular B2 receptors using novel cell-penetrating antagonists to arrest growth and induce apoptosis in human triple-negative breast cancer

Flavio Rizzolio, Martin Savard, Fernand Gobeil, 2018, Oncotarget.

G-protein-coupled receptors, channels, and Na+–H+ exchanger in nuclear membranes of heart, hepatic, vascular endothelial, and smooth muscle cellsThis paper is one of a selection of papers published in this Special Issue, entitled The Nucleus: A Cell Within A Cell.

S. Choufani, S. Chemtob, D. Jacques, 2006 .

The neurokinin‐3 (NK3) and the neurokinin‐1 (NK1) receptors are differentially targeted to mesocortical and mesolimbic projection neurons and to neuronal nuclei in the rat ventral tegmental area

J. Pierce, V. Pickel, A. Lessard, 2009, Synapse.

G-protein-coupled receptors signalling at the cell nucleus: an emerging paradigm.

N. Heveker, M. Leduc, T. Zhu, 2006, Canadian journal of physiology and pharmacology.

Lipopolysaccharide and hypoxia/ischemia induced IL-2 expression by microglia in neonatal brain

M. Rola-Pleszczynski, S. Girard, G. Sébire, 2008, Neuroreport.

Kinin B1 receptor mediates memory impairment in the rat hippocampus

H. Buck, T. Viel, A. Caetano, 2016, Biological chemistry.

Dual kinin B1 and B2 receptor activation provides enhanced blood–brain barrier permeability and anticancer drug delivery into brain tumors

M. Lepage, D. Fortin, W. Neugebauer, 2013, Cancer biology & therapy.

Pharmacological heterogeneity of neurotensin receptors: an in vitro study.

W. Neugebauer, D. Regoli, L. Pheng, 1997, Canadian journal of physiology and pharmacology.

Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency.

Francesco Tedesco, Berhane Ghebrehiwet, Fernand Gobeil, 2009, The Journal of allergy and clinical immunology.

Potentiation of B2 receptor signaling by AltB2R, a newly identified alternative protein encoded in the human bradykinin B2 receptor gene

Jean-François Jacques, X. Roucou, S. Geha, 2021, The Journal of biological chemistry.

Intracrine signaling through lipid mediators and their cognate nuclear G-protein-coupled receptors: a paradigm based on PGE2, PAF, and LPA1 receptors.

M. Leduc, T. Zhu, S. Chemtob, 2006, Canadian journal of physiology and pharmacology.

Intracellular signaling of lipid mediators via cognate nuclear G protein-coupled receptors.

T. Zhu, S. Chemtob, F. Gobeil, 2005, Endothelium : journal of endothelial cell research.

Immunofluorescence revealed the presence of NHE-1 in the nuclear membranes of rat cardiomyocytes and isolated nuclei of human, rabbit, and rat aortic and liver tissues.

K. Hazzouri, D. Jacques, F. Gobeil, 2004, Canadian journal of physiology and pharmacology.

Development of a Novel Noncompetitive Antagonist of IL-1 Receptor1

A. Pshezhetsky, N. Heveker, M. Leduc, 2008, The Journal of Immunology.

Exaggerated vasomotor response to ANG II in rats with fetal programming of hypertension associated with exposure to a low-protein diet during gestation.

P. Pladys, P. Hardy, A. Nuyt, 2006, American journal of physiology. Regulatory, integrative and comparative physiology.

Angiotensin II induced increase in frequency of cytosolic and nuclear calcium waves of heart cells via activation of AT1 and AT2 receptors

K. Hazzouri, N. El-Bizri, D. Jacques, 2005, Peptides.

Cognate Nuclear Receptor Platelet-Activating Factor Mediated Via Its Proinflammatory Gene Induction

S. Choufani, J. Stankova, M. Rola-Pleszczynski, 2002 .

A new biolistic intradermal injector

Serge Marchand, M. Brouillette, J. Moutquin, 2016 .

Novel kinin B1 receptor agonists with improved pharmacological profiles

W. Neugebauer, F. Gobeil, M. Savard, 2009, Peptides.

Kinin B1 receptor antagonists with multi-enzymatic resistance properties.

W. Neugebauer, D. Regoli, F. Gobeil, 2002, Canadian journal of physiology and pharmacology.

Preclinical pharmacology, metabolic stability, pharmacokinetics and toxicology of the peptidic kinin B1 receptor antagonist R-954

D. Regoli, F. Gobeil, P. Sirois, 2014, Peptides.

Bradykinin receptors in GtoPdb v.2021.3

F. Marceau, W. Müller-Esterl, R. Couture, 2021, IUPHAR/BPS Guide to Pharmacology CITE.

Antitumor activity of cell‐penetrant kinin B1 receptor antagonists in human triple‐negative breast cancer cells

S. Chemtob, S. Geha, A. Lessard, 2018, Journal of cellular physiology.

Safety and pharmacokinetics of a kinin B1 receptor peptide agonist produced with different counter-ions

L. Tremblay, W. Neugebauer, D. Regoli, 2016, Biological chemistry.

Non-selectivity of new bradykinin antagonists for B1 receptors.

N. Rhaleb, D. Regoli, F. Gobeil, 1992, Life Science.

Neurokinin receptors (NK1, NK2) in the mouse: a pharmacological study.

D. Regoli, L. Pheng, F. Gobeil, 1997, Canadian journal of physiology and pharmacology.

Kinin receptors in the diabetic mouse.

D. Regoli, L. Pheng, F. Gobeil, 1997, Canadian journal of physiology and pharmacology.

Hyperoxic Exposure Leads to Nitrative Stress and Ensuing Microvascular Degeneration and Diminished Brain Mass and Function in the Immature Subject

P. Hardy, S. Chemtob, F. Sennlaub, 2006, Stroke.

Effect of thrombin and bradykinin on endothelial cell mechanical properties monitored through membrane deformation

Fernand Gobeil, Réjean Lebel, R. Lebel, 2009, Journal of molecular recognition : JMR.

Nitric oxide and reactive oxygen species in the nucleus revisited.

D. Jacques, F. Gobeil, G. Bkaily, 2010, Canadian journal of physiology and pharmacology.

G-protein-coupled receptors, channels, and Na+-H+ exchanger in nuclear membranes of heart, hepatic, vascular endothelial, and smooth muscle cells.

S. Choufani, S. Chemtob, D. Jacques, 2006, Canadian Journal of Physiology and Pharmacology.

2,3-Dinor-5,6-dihydro-15-F(2t)-isoprostane: a bioactive prostanoid metabolite.

J. Morrow, L. Roberts, X. Hou, 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

Antagonists for kinin B1 and B2 receptors in the mouse.

W. Neugebauer, D. Regoli, L. Pheng, 1997, Canadian journal of physiology and pharmacology.

Kinin B2 Receptor Activation Prevents the Evolution of Alzheimer’s Disease Pathological Characteristics in a Transgenic Mouse Model

M. Irigoyen, Mariana Toricelli, Helena Nascimento Malerba, 2020, Pharmaceuticals.

High resolution imaging and function of nuclear G protein-coupled receptors (GPCRs).

J. Rivera, A. Ribeiro-da-Silva, S. Chemtob, 2015, Methods in molecular biology.

Characterization of moderate tendinopathy in ex vivo stress-deprived rat tail tendons

F. Gobeil, M. Savard, È. Langelier, 2019, Biomedical engineering online.

Surface Plasmon Resonance Monitoring of Cell Monolayer Integrity: Implication of Signaling Pathways Involved in Actin-Driven Morphological Remodeling

P. Charette, V. Aimez, E. Escher, 2008, Cellular and molecular bioengineering.

VRQ397 (CRAVKY): a novel noncompetitive V2 receptor antagonist.

N. Heveker, F. Hamdan, G. Guillon, 2009, American journal of physiology. Regulatory, integrative and comparative physiology.

Pharmacological characterization of SR 142801: a new non-peptide antagonist of the neurokinin NK-3 receptor.

Q. Nguyen, J. Breliere, D. Regoli, 1996, Pharmacology.

Characterization of kinin receptors by bioassays.

D. Regoli, F. Gobeil, 1994, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

Neurokinin receptors in the guinea pig ileum.

Q. Nguyen, D. Regoli, F. Gobeil, 1996, Pharmacology.